We aim to improve the lives of patients with ocular surface disease (OSD) with our pioneering platelet-derived regenerative biologic (PRB) therapy. PRB harnesses the same regenerative potential that underlies bespoke autologous treatments such as platelet-rich plasma (PRP) — but in the form of a mass-manufactured treatment that is standardized, off-the-shelf, and low enough cost to be able to reach all OSD patients. Stellular has proven the efficacy of PRB in animal models and has established scalable manufacturing methods that will enable clinical trials and commercial production. We are pursuing initial clinical proof of concept in Sjogren's syndrome-related dry eye and are poised to expand rapidly into the broader OSD market.
Company Details
- Employees
- 10
- Address
- Watertown, Ma 02472, Us
- Industry
- Biotechnology
- Website
- https://www.stellularbio.com/
- HQ
- Watertown, MA
Stellular Bio Questions
Stellular Bio's website is https://www.stellularbio.com/
Stellular Bio's LinkedIn profile is https://www.linkedin.com/company/stellular-bio
Stellular Bio has
10 employees.
View email and phone details for 10
employees at Stellular Bio.
Stellular Bio's industry is
Biotechnology
Stellular Bio's top competitors are
Scholar Rock,
Allovir,
Lyndra Therapeutics,
Entact Bio,
Octagon Therapeutics,
Catie's Closet, Inc,
Robigo,
Strm.bio,
Elevatebio,
Parallel Bio.
Stellular Bio's categories are Biotechnology
